OmniAb, Inc. Common Stock (OABI) is a publicly traded Healthcare sector company. As of May 21, 2026, OABI trades at $2.60 with a market cap of $331.99M and a P/E ratio of -5.55. OABI moved +9.28% today. Year to date, OABI is +39.46%; over the trailing twelve months it is +67.53%. Its 52-week range spans $1.22 to $4.87. Analyst consensus is strong buy with an average price target of $7.50. Rallies surfaces OABI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OmniAb Inc Q1 Revenue Seen at $5.69M, Full-Year Forecast Cut 13%: Consensus estimates forecast OmniAb Inc’s Q1 2026 revenue at $5.69 million with a loss of $0.10 per share. Full-year 2026 revenue projections have been cut from $32.00 million to $27.89 million while EPS forecasts have improved slightly from -$0.42 to -$0.40.
| Metric | Value |
|---|---|
| Price | $2.60 |
| Market Cap | $331.99M |
| P/E Ratio | -5.55 |
| EPS | $-0.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.87 |
| 52-Week Low | $1.22 |
| Volume | 2.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $28.94M |
| Net Income | $-54.29M |
| Gross Margin | 0.00% |
5 analysts cover OABI: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.50.